CRLF3 as A Potential Drug Target for Various Diseases (G51379)

Target Name: CRLF3

NCBI ID: G51379

CRLF3

CRLF3 as A Potential Drug Target for Various Diseases

CRLF3 (CRLF3_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and lungs. It is a member of the CRLF family, which is known for its role in regulating the formation of blood vessels and maintain tissue barrier integrity.

Recent studies have identified CRLF3 as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because CRLF3 has been shown to play a role in the development and progression of these conditions.

One of the key reasons for the potential of CRLF3 as a drug target is its involvement in the regulation of angiogenesis. Angiogenesis refers to the generation and maintenance of new blood vessels, which is an important reason for the occurrence and development of many diseases. CRLF3 plays an important role in angiogenesis as it promotes the proliferation and migration of vascular endothelial cells and regulates vascular permeability.

In addition, CRLF3 is also closely related to the occurrence and development of tumors. Studies have shown that the expression level of CRLF3 is positively correlated with the aggressiveness and growth rate of various tumors. Therefore, reducing the expression level of CRLF3 may become an effective tumor treatment strategy.

CRLF3 is also closely related to the occurrence and development of neurodegenerative diseases. For example, CRLF3 has been shown to be involved in the development of Alzheimer's disease, a neurodegenerative disorder that is characterized by the progressive loss of brain cells.

In addition to its potential role in neurodegenerative diseases, CRLF3 has also been shown to be involved in the regulation of the immune response. This is important because an imbalance in the immune response has been implicated in many autoimmune disorders.

One of the key features of CRLF3 is its ability to form a tight junction, which is a barrier that helps to maintain the integrity of tissues. This is important because the tight junction helps to regulate the movement of cells and the passage of substances into and out of cells.

CRLF3 has also been shown to play a role in the regulation of cell signaling pathways. This is important because many diseases are caused by changes in the levels or patterns of signaling pathways.

In conclusion, CRLF3 is a protein that has been identified as a potential drug target for a variety of diseases. Its involvement in the regulation of angiogenesis, tumor initiation and progression, development of neurodegenerative diseases, and cell signaling pathways Regulation and other aspects are of great significance. Therefore, studying CRLF3 as a drug target or biomarker has important clinical significance.

Protein Name: Cytokine Receptor Like Factor 3

Functions: May play a role in the negative regulation of cell cycle progression

The "CRLF3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CRLF3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets